Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System

NCT: NCT07118358 · RECRUITING

NCT IDNCT07118358
StatusRECRUITING
Start Date2026-03-16
Completion2028-04

Brief Summary

The objective of this Investigational Device Exemption trial is to confirm the safety and performance of the LivIQ leadless pacemaker system, in patients with a Class I or II indication for ventricular pacing (VVI/VDD) according to applicable guidelines. An integrated atrioventricular synchrony sub-study (AVS) is specifically designed to evaluate the AVS performance of the LivIQ system.

Frequently Asked Questions

What is BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System?

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System is a clinical trial registered under NCT07118358. Current status: RECRUITING.

What is the status of NCT07118358?

The current status of NCT07118358 (BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System) is: RECRUITING.

When did BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System start?

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System started on 2026-03-16.

Related Devices

PMA P150033 Leadless pacemaker Medtronic, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑